Trial Profile

Intra-patient, head-to-head comparator study of urinary radioactivity between POSLUMA and piflufolastat F 18 in men with low prostate-specific antigen (PSA) biochemical recurrence following radical prostatectomy

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 02 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Mar 2026 New trial record
27 Feb 2026 According to Blue Earth Diagnostics media release, the results from the study has been published in the European Journal of Nuclear Medicine and Molecular Imaging and were just presented at the 2026 ASCO Genitourinary Cancers Symposium (ASCO GU), on February 26, 2026, in San Francisco, California.
27 Feb 2026 Results presented in the Blue Earth Diagnostics media release

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com